Your browser doesn't support javascript.
loading
An MDS Evidence-Based Review on Treatments for Huntington's Disease.
Ferreira, Joaquim J; Rodrigues, Filipe B; Duarte, Gonçalo S; Mestre, Tiago A; Bachoud-Levi, Anne-Catherine; Bentivoglio, Anna Rita; Burgunder, Jean-Marc; Cardoso, Francisco; Claassen, Daniel O; Landwehrmeyer, G Bernard; Kulisevsky, Jaime; Nirenberg, Melissa J; Rosser, Anne; Roth, Jan; Seppi, Klaus; Slawek, Jaroslaw; Furr-Stimming, Erin; Tabrizi, Sarah J; Walker, Francis O; Vandenberghe, Wim; Costa, João; Sampaio, Cristina.
Afiliação
  • Ferreira JJ; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Rodrigues FB; Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal.
  • Duarte GS; CNS - Campus Neurológico, Torres Vedras, Portugal.
  • Mestre TA; Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal.
  • Bachoud-Levi AC; CNS - Campus Neurológico, Torres Vedras, Portugal.
  • Bentivoglio AR; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
  • Burgunder JM; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Cardoso F; Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal.
  • Claassen DO; Centro de Estudos de Medicina Baseada na Evidência, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Landwehrmeyer GB; Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
  • Kulisevsky J; Parkinson disease and Movement Disorders Centre, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, The University of Ottawa Brain and Mind Research Institute, Ottawa, Ontario, Canada.
  • Nirenberg MJ; National Centre of Reference for Huntington's Disease, Neurology Department, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France.
  • Rosser A; Neuropsychologie Interventionelle Lab, INSERM U955 E01B, PSL University, Paris, France.
  • Roth J; Université Paris Est Créteil, Créteil, France.
  • Seppi K; Istituto di Neurologia, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Slawek J; Movement Disorder Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Furr-Stimming E; Swiss Huntington Center, Neurozentrum Siloah AG, Muri bei Bern, Switzerland.
  • Tabrizi SJ; Department of Neurology, University of Bern, Bern, Switzerland.
  • Walker FO; Movement Disorders Unit, Neurology Service, Internal Medicine Department of the Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Vandenberghe W; Department of Neurology, Division of Behavioral and Cognitive Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Costa J; Department of Neurology, University of Ulm, Ulm, Germany.
  • Sampaio C; Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Mov Disord ; 37(1): 25-35, 2022 01.
Article em En | MEDLINE | ID: mdl-34842303

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coreia / Doença de Huntington / Apatia / Transtornos dos Movimentos Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coreia / Doença de Huntington / Apatia / Transtornos dos Movimentos Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal